This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
PCI Pharma Services (PCI) is pleased to announce that Al Moss has assumed the role of Vice President and General Manager of its Philadelphia, PA location. The site serves as PCI’s corporate headquarters as well as a Center of Excellence for contract packaging services for commercial medicines, medical devices and consumer healthcare products. PCI operates an extensive global supply network across North America and Europe, supporting medicines destined to over 100 countries worldwide.
Al comes to PCI with outstanding credentials and a proven record of results, holding progressive leadership positions at industry-leading companies including Procter and Gamble, General Mills, SABMiller, British Petroleum (BP) and most recently at Coty, Inc. where he led North American Skincare and Fragrance Operations.His track record of demonstrated success throughout his career spans virtually all elements of supply chain, including distribution and warehousing, logistics and transportation, supplier enablement, production, and customer capability development. In addition to his professional experience, Al holds a Bachelor’s degree in Industrial and Systems Engineering from North Carolina A&T State University, an MBA in Operations Management from the University of Iowa, and a Master’s Degree in Supply Chain Management from Penn State.
"We are very excited to have Al join the PCI team," stated Bill Mitchell, Chief Executive Officer. “Al brings a diverse background in supply chain and production and truly understands the needs of our customers. His personal commitment to customer satisfaction underscores the company's focus on true strategic partnership and providing the industry’s leading customer experience. Al's demonstrated leadership has him well positioned to lead the Philadelphia team."
The PCI Philadelphia facility recently expanded site capacity by adding additional high speed bottling and blister packaging lines, as well as a significant expansion of its Serialization capacity, part of a multi-site installation that will have PCI realize more than 80 lines of Serialization readiness. Other notable capital investments include the expansion of the site’s 2-8C Cold Chain storage, adding to the Cold Chain capabilities at the Rockford, IL and Bridgend, UK facilities. This is the latest in a series of significant investments by PCI to facilitate their strategic expansion of services, positioning PCI to best support trends in the pharmaceutical marketplace
